Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy

European Journal of Cardio-thoracic Surgery

Volumn 20, Issue 4, 2001, Pages 700-704

  Novoa, N ^a   Varela, G ^a   Jimenez M F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Morbidity; Neoadjuvant chemotherapy; Non small cell lung carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; COMPARATIVE STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0035488934     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(01)00876-4     Document Type: Article

References (25)

1. Pastorino U. Benefits of neoadjuvant chemotherapy in NSCLC. Chest 1996;109(Suppl 5):96S-101S.
2. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
3. Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR. Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg 1995;109:473-483.
4. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Canela M, Ariza A, Skacel Z, Morera-Prat J, Abad A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with nonsmall-cell lung cancer. N Engl J Med 1994;330:153-158.
5. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992;53:992-998.
6. Fowler WC, Langer CJ, Curran WJ, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993;55:986-989.
7. Bernard A, Ferrand L, Hagry O, Benoit L, Cheynel N, Favre JP. Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg 2000;70:1161-1167.
8. Bonomi P, Faber LP, Warren W, Lincoln S, LaFollette S, Sharma M, Recine D. Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation. Semin Oncol 1997;24(Suppl 12):123-129.
9. Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardio-thorac Surg 1997;11:445-449.
10. Siegenthaler M, Pisters K, Merriman K, Roth J, Swisher S, Walsh G, Vaporiciyan A, Smythe W, Putnam JJ. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 2001;71:1105-1112.
11. Nakahara K, Monden Y, Ohno K, Miyoshi S, Maeda H, Kawashima Y. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg 1985;39:260-265.
12. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn PA. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 2000;119:429-439.
13. Langer CJ. Induction or neoadjuvant therapy in resectable non-small cell lung cancer. Semin Oncol 1999;26(Suppl 15):34-39.
14. Friedel G, Hruska D, Budach W, Wolf M, Kyriss T, Hurtgen M, Eulenbruch HP, Dierkesmann R, Toomes H. Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer. Lung Cancer 2000;30:175-185.
15. De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W, Verschakelen J, Lerut T. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardio-thorac Surg 1997;12:706-712.
16. De Leyn P, Vansteenkiste J, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pretreatment mediastinoscopy. Eur J Cardio-thorac Surg 1999; 15:608-614.
17. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 1992;101:1332-1337.
18. de Perrot M, Licker M, Reymond MA, Robert J, Spiliopoulos A. Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J 1999;14:419-422.
19. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J 1996;9:7-10.
20. Varela G, Cordovilla R, Jimenez MF, Novoa N. Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection. Eur J Cardio-thorac Surg 2001;19:351-354.
21. Jagoe RT, Goodship TH, Gibson GJ. The influence of nutritional status on complications after operations for lung cancer. Ann Thorac Surg 2001;71:936-943.
22. Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000;70:1826-1831.
23. Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer. Ann Thorac Surg 1995;60:586-591.
24. Vora SA, Daly BD, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S, Dipetrillo TA. High dose radiation therapy and chemotherapy as induction treatment for stage III non-small cell lung carcinoma. Cancer 2000;89:1946-1952.
25. Pujol JL, Le Chevalier T, Ray P, Gautier V, Rouanet P, Arriagada R, Grunenwald D, Michel FB. Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer. Lung Cancer 1995;12(Suppl 1):S107-S118.